Capra Biosciences
Biology-powered production of renewable chemicals.
Sterling, United States · Founded 2020 · $12.3M raised
- Headquarters
- Sterling, Virginia
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- caprabiosciences.com
- Total Funding
- $12.3M
- Last Round
- $7.5M GrantJul 2024
- Rounds
- 3
About
Capra Biosciences uses patented bioreactor technology to produce high-performance, renewable bio-based chemicals affordably and sustainably. The company is revolutionizing chemical production by transforming byproducts into valuable materials, with applications in pharmaceutical ingredient manufacturing and industrial chemicals. Capra has received a $7.5M DARPA project agreement to scale its platform.
Summary
Capra Biosciences is a company based in Sterling, United States, founded in 2020. It has raised $12.3M in total across 3 rounds, most recently a $7.5M Grant round in Jul 2024. Investors include BioMADE Consortium, SOSV and Alumni Ventures.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jul 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
